This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Hochschule Darmstadt. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Alexander Kleinschek: Innovator in HDAC Inhibitors
Introduction
Alexander Kleinschek is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of selective HDAC8 inhibitors. His work focuses on small molecule compounds that have potential therapeutic applications.
Latest Patents
Kleinschek holds a patent for "Selective HDAC8 inhibitors and their uses." This invention relates to small molecule compounds based on benzopyrimido- or benzoimidazo-thiazin-imine, along with their synthesis intermediates. The compounds are designed to act as HDAC inhibitors, specifically targeting HDAC8. They are intended for use in the treatment of cancer and as therapeutic agents for eukaryotic parasites.
Career Highlights
Kleinschek is affiliated with Hochschule Darmstadt, where he contributes to research and development in his field. His innovative work has led to advancements in cancer treatment methodologies and the understanding of eukaryotic parasites.
Collaborations
Some of his notable coworkers include Franz-Josef Meyer-Almes and Christian Meyners. Their collaborative efforts have furthered research in the area of HDAC inhibitors and their applications.
Conclusion
Alexander Kleinschek's contributions to the field of HDAC inhibitors highlight his role as an important inventor in medicinal chemistry. His work continues to pave the way for new therapeutic strategies in cancer treatment and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile